Accendra Health Inc (ACH): Insider sold ~$4K
Bernocchi Perry A, Insider at Accendra Health Inc, sold ~$4K of Accendra Health Inc shares.
- ~$4K
- Approx. value · 33K sh @ $0.122
- 281K
- Holds after · shares reported
- Traded
- Nov 16, 2026
- Filed
- Nov 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 16, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On September 17, 2026, Accendra Health, Inc. (the “Company” or “Accendra Health”) announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer.”
- Sep 16, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 22, 2026, Accendra Health and Mr. Gardner-Smith, the Company’s next President and Chief Executive Officer, mutually agreed to an effective start date of October 5, 2026.”
- Oct 6, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On October 6, 2026 Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive…”
- Oct 7, 20265% stakeBANK OF AMERICA CORP /DE/ reported a passive stake (13G) of 10.8%
- Oct 27, 2026Company filing · Form 8-K · Listing notice, Reg FDReceived a notice from its stock exchange, and shared information with investors“On October 27, 2026, Accendra Health, Inc. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE’s Listed Company Manual (“Section 802.01B”) that the Company have an average market capitalization of not less than $50.0 million over a consecutive 30 trading-day period and…”
- Oct 29, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Oct 29, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 29, 2026, Perry A. Bernocchi, the Company’s Executive Vice President, Chief Operating Officer, entered into a transition agreement with the Company under which Mr. Bernocchi will cease to be an executive officer and will serve as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless his employment ends earlier.”
- Nov 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Nov 12, 20265% stakePARADIGM CAPITAL MANAGEMENT INC/NY reported a passive stake (13G) of 5.1%
- Nov 16, 2026 · this disclosureInsiderInsider sold ~$4K of ACH shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Accendra Health Inc
For Accendra Health Inc, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACH page.
How this filing works
Explore the data
Common questions
Which Accendra Health Inc (ACH) insider traded, and how much?
Bernocchi Perry A, Insider at Accendra Health Inc, sold ~$4K of Accendra Health Inc shares. 33K shares at $0.12.
When did it happen, and when was it made public?
Traded: Nov 16, 2026. Filed: Nov 17, 2026. That is 1 day between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Accendra Health Inc recently?
For Accendra Health Inc, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days. They are listed on the ACH page.
Does this mean ACH stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Accendra Health Inc
- SEC Form 144Nov 16, 2026
- SEC Schedule 13GNov 12, 2026
- SEC Schedule 13GOct 7, 2026
- SEC Form 4Aug 15, 2025
- SEC Form 4Aug 15, 2025
- SEC Form 4Aug 15, 2025
Everything OQRO holds on this company is on its ACH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data